BRIEF published on 09/17/2024 at 10:27, 1 year 2 months ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 1 year 2 months ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:22, 1 year 2 months ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
BRIEF published on 09/06/2024 at 11:51, 1 year 2 months ago Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 08/22/2024 at 12:52, 1 year 3 months ago Successful VAT recovery for Novacyt Financial Health Regulation Novacyt VAT Recovered DHSC Dispute
BRIEF published on 08/22/2024 at 12:49, 1 year 3 months ago Successful VAT reclaim of £12.2 million by Novacyt Financial Settlement Diagnostics Novacyt VAT Reclaim HMRC
PRESS RELEASE published on 08/22/2024 at 12:44, 1 year 3 months ago Successful VAT reclaim of £12.2 million Novacyt successfully reclaims £12.2 million in VAT from HMRC, increasing net cash position by over £7.0 million. Inside information disclosed Inside Information Novacyt VAT Reclaim Net Cash Position HMRC
BRIEF published on 07/25/2024 at 12:32, 1 year 4 months ago Novacyt publishes its unaudited half-yearly activity report Acquisition R&D Turnover Novacyt Semestrial Report
BRIEF published on 07/25/2024 at 12:29, 1 year 4 months ago Novacyt Announces Half Year Trading Update for 2024 Revenue Growth Strategic Initiatives Regulatory Approvals Financial Update New Products
PRESS RELEASE published on 07/25/2024 at 12:24, 1 year 4 months ago Half Year Trading Update Novacyt S.A. announces unaudited trading update for H1 2024, showcasing revenue growth, cash position, cost-saving measures, and strategic progress across clinical, instrumentation, and R&D segments Revenue Growth Trading Update Cost-saving Measures Novacyt S.A. R&D Progress
Published on 12/05/2025 at 02:35, 7 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 20 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 30 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 55 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour 15 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
